Unicycive Therapeutics, Inc
  • About
    • Our Story
    • Our Focus
    • Our Team
    • Board of Directors
  • Our Science
    • Our Approach
    • Pipeline
    • Oxylanthanum Carbonate (OLC)
    • UNI-494
    • Publications & Press
  • Investors
  • Contact
    • Careers

Financial Results

Investors

Investors

  • Overview
  • News
  • Events & Presentations
    • IR Calendar
    • Presentations
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Financial & Stock Info
    • Overview
    • Financial Results
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • Resources
    • Overview
    • Contacts
    • FAQ
    • Email Alerts

  • Financial & Stock Info

  • Overview
  • Financial Results
  • Quote
  • Charts
  • Historical Data
  • Analyst Coverage

2025

FY 2025

Fiscal Year Ended Dec 31, 2025
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP HTML

Q3 2025

Quarter Ended Sep 30, 2025
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP HTML

Q2 2025

Quarter Ended Jun 30, 2025
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP HTML

Q1 2025

Quarter Ended Mar 31, 2025
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2024

FY 2024

Fiscal Year Ended Dec 31, 2024
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2024

Quarter Ended Sep 30, 2024
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2024

Quarter Ended Jun 30, 2024
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2024

Quarter Ended Mar 31, 2024
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2023

FY 2023

Fiscal Year Ended Dec 31, 2023
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2023

Quarter Ended Sep 30, 2023
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2023

Quarter Ended Jun 30, 2023
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2023

Quarter Ended Mar 31, 2023
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2022

FY 2022

Fiscal Year Ended Dec 31, 2022
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2022

Quarter Ended Sep 30, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2022

Quarter Ended Jun 30, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2022

Quarter Ended Mar 31, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2021

FY 2021

Fiscal Year Ended Dec 31, 2021
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2021

Quarter Ended Sep 30, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2021

Quarter Ended Jun 30, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML
  • Email Alerts
  • Contacts
  • RSS News Feed
Unicycive Theraputics, Inc

About
Our story
 Our focus
 Our team
 Boards of Directors

Our Science
Our Approach
 Therapeutic Pipeline
 OLC
UNI-494
Publications & Press

Investors

Contact
Careers

1975 W El Camino Real, Ste 204
Mountain View, CA 94040
+1 (650) 351-4495
info@unicycive.com

  • LinkedIn
  • YouTube
  • Facebook
  • Instagram
  • Twitter

Copyright © 2026 Unicycive

Legal Notices and Terms of Use Privacy Policy Ad and Cookie Policy